GLAXOSMITH ended its 2021FY financial period on a positive note as its topline surged moderately by 5.42%YoY to NGN22.45bn (from NGN21.30bn in 2020FY). The topline expansion was spearheaded by growth in the Consumer Healthcare segment (+16.63%YoY) while the Pharmaceuticals Segment grew by 0.77%YoY to NGN15.16bn (vs NGN15.05bn in 2020FY). Hence, revenue stood at NGN22.45bn in 2021FY compared to NGN21.30bn in the previous financial period. In the first quarter of 2022, the firm also recorded an impressive expansion in topline. We note that the revenue performance in the quarter represents its highest quarterly revenue in 24 quarters (since Q1:2016).
You May Also Like
The Week in View – Friday, 16th Dec 2022
- December 19, 2022
Kindly find attached The Week in View – 16th December 2022
Daily Stock Market Update – 3rd August 2021
- August 4, 2021
Kindly use the link below to access our Daily Stock Market Report for the 3rd August 2021 Daily…
Weekly Stock Recommendation and Corporate Benefits Trigger – August 3rd 2020
- August 3, 2020
The bulls dominated the Nigerian equities market for the second week in a row as the NSEASI gained…
Earnings Update- CADBURY- H1:2021
- August 25, 2021
Kindly find the link below for CADBURY’s earnings update for H1:2021. Regards,Earnings Update- CADBURY- H1-2021.
Note on NNPCL Loan from AFREXIM Bank.
- September 5, 2023
Kindly find attached. Note on NNPCL Loan from AFREXIM Bank
Weekly Corporate Benefit Trigger for 23rd August, 2021
- August 23, 2021
Dear All, Kindly find attached our Weekly Corporate Benefit Trigger Report. CORPORATE BENEFIT TRIGGER – 23rd August 2021